Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy.
Hiroyuki SuzukiHitomi SezakiFumitaka SuzukiKayoko KasuyaTomoya SanoShunichirou FujiyamaYusuke KawamuraTetsuya HosakaNorio AkutaSatoshi SaitohMasahiro KobayashiYasuji AraseKenji IkedaYoshiyuki SuzukiHiromitsu KumadaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
Long-term treatment with RFX was beneficial for HE and liver function in patients with HE. Furthermore, the recurrence rate of HE was low in RFX-treated patients without ascites. Thus, long-term treatment with RFX could be effective for the management of Japanese patients with HE.